Rheumatology
News
FDA approves IL-17A antagonist for treating psoriatic arthritis
Ixekizumab was compared with placebo in two phase 3 studies of patients with psoriatic arthritis.
Conference Coverage
Blisibimod shows mixed results for lupus in phase 3 trial
SAN DIEGO – The drug did not meet its primary endpoint but was associated with steroid sparing, decreased urine protein, and improved biomarker...
Conference Coverage
Study explores why RA patients discontinue methotrexate
SAN DIEGO – Patients had wide-ranging reasons for why they stopped methotrexate, and rheumatologists did not specify the same reasons.
Conference Coverage
Novel agent found to benefit Sjögren’s patients
SAN DIEGO – Multiple doses of the investigational agent CFZ533 administered for 24 weeks in patients with primary Sjögren’s syndrome were safe and...
Conference Coverage
Higher water intake linked to less hyperuricemia in gout
SAN DIEGO – Study provides more evidence to urge patients to hydrate.
Conference Coverage
Race may transcend social, geographical parameters in lupus mortality
SAN DIEGO – SLE mortality parameters did not vary among socially advantaged and disadvantaged black Americans.
Conference Coverage
Proposed SLE classification criteria prove highly sensitive, specific
SAN DIEGO – New classification criteria for systemic lupus erythematosus had a sensitivity of 98% and a specificity of 97%.
Conference Coverage
For women with RA, small-joint surgery rate nearly twice that of men
SAN DIEGO – The rate of small-joint procedures is declining for both sexes.
Conference Coverage
VIDEO: Advanced alternative payment model for RA set to undergo testing
SAN DIEGO – The RA APM helps to reduce barriers to good care by providing adequate reimbursement for cognitive services through monthly payments...
News
FDA: Febuxostat may have increased heart-related death risk
The agency reported preliminary findings from a postmarketing safety study started after febuxostat’s approval in 2009.
Conference Coverage
Injectable agent found to improve knee function in OA patients
SAN DIEGO – There were no measurable between-knee differences in cartilage thickness or volume but statistically significant and clinically...